Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients
Bei Hu(Huazhong Agricultural University), Wael Saber(Medical College of Wisconsin), Melhem Solh(Johns Hopkins Hospital), Ronald Sobecks(Cleveland Clinic), Jörge E. Cortes(Augusta University Health), Andrew Daly, Mohamed A. Kharfan‐Dabaja(Jacksonville College), Aaron T. Gerds(Cleveland Clinic), Rebecca S. Tidwell(The University of Texas MD Anderson Cancer Center), Yoshihiro Inamoto, Zhen‐Huan Hu(Medical College of Wisconsin), Marcos de Lima(The Ohio State University), Zachariah DeFilipp(Harvard University), Jan Černý(Worcester Memorial Hospital), Michael R. Grunwald(Levine Cancer Institute), Hans C. Lee(The University of Texas MD Anderson Cancer Center), Richard E. Champlin(The University of Texas MD Anderson Cancer Center), Nasheed Hossain(Loyola University Chicago), Elias Jabbour(The University of Texas MD Anderson Cancer Center), Sachiko Seo(National Cancer Center Hospital East), Xuelin Huang(The University of Texas MD Anderson Cancer Center), Guillermo Garcia‐Manero(The University of Texas MD Anderson Cancer Center), Taiga Nishihori(Moffitt Cancer Center), Baldeep Wirk(Boston University), Uday Popat(The University of Texas MD Anderson Cancer Center), Ulrike Bacher(Hattiesburg Clinic), Celalettin Üstün(Rush University Medical Center), Richard F. Olsson(AstraZeneca (Netherlands)), Edwin P. Alyea(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Bart L. Scott(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jane L. Liesveld(Strong Memorial Hospital), Mahmoud Aljurf(King Faisal Specialist Hospital & Research Centre), Mark R. Litzow(Mayo Clinic in Arizona), Srđan Verstovšek(Unknown), Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Görgün Akpek(Banner MD Anderson Cancer Center), Bipin N. Savani(Vanderbilt University Medical Center), Hagop M. Kantarjian(The University of Texas MD Anderson Cancer Center), Xiao Lin(The University of Texas MD Anderson Cancer Center), David I. Marks(University Hospitals Bristol NHS Foundation Trust), Tamila L. Kindwall‐Keller(MetroHealth Medical Center), Gregory A. Hale(Johns Hopkins University), Jack W. Hsu(University of Florida Health), Kwang Woo Ahn(Medical College of Wisconsin), Rammuriti T. Kamble(Baylor College of Medicine), Farhad Ravandi(The University of Texas MD Anderson Cancer Center)
Cited by 27
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k